Victoza® (liraglutide) is a prescription drug that provides Type 2 diabetics with an injectable form of glucagon-like peptide 1 (GLP-1) which simulates insulin and helps the body to metabolize blood sugar. According to clinical trials conducted by the U.S. Food and Drug Administration (FDA), taking the drug may increase the risk of serious health complications, including pancreatic cancer.
If you or a loved one developed pancreatic cancer after receiving injections of Victoza, you may be among the many who are choosing to file a Victoza lawsuit. At Cory Watson Attorneys, we’ve helped recover $2 billion for clients nationwide, and we’re here to protect your rights to maximum compensation.
Call (877) 562-0000 or complete a free initial consultation form to get in touch with our 24/7 team today. There is no obligation to proceed, and your case review is 100% free and confidential.
Pancreatic Cancer Linked to Victoza®
A 2011 study conducted by researchers at the University of California, Los Angeles, and published by the medical journal Gastroenterology showed that GLP-1 drugs, like Victoza, can cause an almost threefold increase in the risk of a patient developing pancreatic cancer.
Contact a Victoza® Lawyer About Your Potential Lawsuit
If you or someone you love took Victoza and experienced pancreatic cancer, you are not alone. Research indicates that Victoza and other Type 2 diabetes drugs may be to blame for serious and potentially deadly side effects.
The legal team at Cory Watson Attorneys can provide a free case review if you believe your illness was caused by taking Victoza. Fill out our free initial consultation form or dial (877) 562-0000 to get started now.
Victoza® is a registered trademark of Novo Nordisk and is used here only to identify the product in question.
This law firm is not associated with, sponsored by, or affiliated with Gastrointerology; Novo Nordisk; Public Citizen; Reuters; The University of California, Los Angeles; the U.S. Food and Drug Administration